• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
34.23
117820.2
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.89
 

baba arts ltd
Subros gains as Q4 PAT jumps 7% YoY to Rs 49 cr
May 19,2026

Revenue from operations rose 16.01% year-on-year (YoY) to Rs 1,049.76 crore in the quarter ended 31 March 2026.

Profit before tax stood at Rs 66.33 crore in the fourth quarter of FY26, up 7.27% YoY.

During the quarter, EBITDA marginally rose 0.84% YoY to Rs 100.07 crore while EBITDA margin stood at 9.57%.

The board has recommended a dividend of Rs 3 per equity share of face value Rs 2 each (150%) for the financial year ended March 31, 2026. The dividend will be paid to members whose names appear in the register of members as on September 11, 2026, the record date fixed for the purpose.

Subros was incorporated in 1985 as a joint venture public limited company with Suri family of India (36.79% ownership), Denso Corporation, Japan (20% ownership) & Suzuki Motor Corporation, Japan (11.96% ownership). It is engaged in the business of manufacturing and supplying Auto Air Conditioning products for all major Automakers in Passenger and Commercial Vehicle Space.